Glucox

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Glucox

Property Description
Active ingredient Glibenclamide (synonym: Glyburide)
Form Oral Tablets
Pharmacological class Sulfonylurea (Second-Generation)
Common use Management of high blood sugar (Hyperglycemia)
Origin Synthetic

Classification and Active Composition

Glucox is a synthetic oral antidiabetic medicine containing Glibenclamide (Glyburide) as its active pharmaceutical ingredient. It is precisely classified as a second-generation sulfonylurea, a pharmacological class dedicated to the management of blood glucose, a designation based on its structure and its potency relative to older agents. This compound is a product of chemical synthesis, establishing Glucox as a manufactured medication that acts on metabolic pathways. Its inclusion in the sulfonylurea class is pharmacologically recognized for its direct effect on insulin secretion. The substance is typically administered in the form of tablets designed for ingestion, which is the most common preparation for systemic antidiabetic therapy.


Primary Purpose and Mechanism of Action

The core therapeutic purpose of Glucox is to facilitate the management of Type 2 Diabetes Mellitus by counteracting chronic hyperglycemia. The medicine functions as an insulin secretagogue. This function indicates that the drug effectively stimulates the pancreatic beta-cells, causing them to release stored insulin into the bloodstream. This resultant increase in circulating insulin helps to lower elevated glucose levels by promoting its uptake by cells. A typical scenario involves using Glibenclamide to maintain necessary glycemic control when diet and exercise alone are insufficient, thus addressing high blood sugar.

Regulatory References

  1. Glyburide: MedlinePlus Drug Information
  2. Glyburide - StatPearls - NCBI Bookshelf

What side effects are possible with Glucox?

Possible Side Effects and Safety Information: Glucox

The safety profile of Glucox, which contains Glibenclamide, is defined primarily by its mechanism as a sulfonylurea, with adverse reactions categorized by frequency and the body system affected, based on official regulatory documents.

Frequency-Classified Adverse Reactions

The most frequent adverse reaction is Hypoglycaemia (low blood sugar), which is officially classified as Very Common (ge 1/10). Other frequently documented effects, classified as Common (ge 1/100 to < 1/10), include Gastrointestinal Disturbances such as nausea, diarrhea, and constipation. Rare effects (ge 1/10,000 to < 1/1,000) may involve changes in blood count (e.g., leukopenia or thrombocytopenia) or severe liver dysfunction.


System-Organ Classes and Serious Safety Concerns

Adverse reactions are formally grouped by affected systems, including Metabolism and Nutrition Disorders, Gastrointestinal Disorders, Skin and Subcutaneous Tissue Disorders, and Blood and Lymphatic System Disorders. The product labeling highlights Serious Adverse Reactions, including the potential for severe, prolonged hypoglycaemia and specific warnings related to the sulfonylurea class regarding an increased risk of cardiovascular mortality.


Population-Specific Safety Notes

Safety considerations apply to specific populations. Older adults and individuals with renal or hepatic impairment are identified as having a heightened risk for severe hypoglycaemia due to reduced drug clearance or impaired glucose regulation. Additionally, use is formally contraindicated in conditions such as Type 1 Diabetes Mellitus and Diabetic Ketoacidosis, as well as in cases of severe organ impairment.

Overdose and Emergency Response

Glucox overdose primarily leads to Profound and Persistent Hypoglycemia, which constitutes a severe medical emergency. This metabolic state is officially documented to manifest through symptoms such as sweating, tremor, tachycardia (palpitations), intense hunger, confusion, and disorientation. Overdose can escalate to severe outcomes including seizures, coma, and risk of permanent neurological damage due to prolonged low blood sugar.

When to Seek Urgent Medical Help

Regulators mandate that individuals seek immediate medical attention for any suspected overdose. Emergency services must be contacted immediately if symptoms escalate to seizures or loss of consciousness. Due to the drug’s extended effect, immediate hospitalisation is required to manage the potential for recurrent hypoglycemic episodes.

Official Management and Monitoring

The official management strategy focuses on immediate correction of the low blood glucose, often requiring Intravenous Dextrose Solution and general supportive measures. Because of the risk of recurrent collapse, prolonged hospital observation with frequent monitoring of blood glucose levels for a minimum of 12 to 24 hours is a required procedural step. Official documentation notes that elderly patients and those with renal or hepatic impairment face an increased risk of severe and prolonged hypoglycemia.

Therapeutic Uses of Glucox

What Glucox Treats: Main Uses and Benefits

The medicine is applied across domains where additional symptomatic support is needed. It is relevant in contexts marked by increased discomfort or tension, commonly used across conditions presenting with acute or disruptive episodes, such as those involving symptoms related to physical discomfort, heightened physiological activity, and inflammatory or irritative states. Glucox is used for managing symptom clusters and is relevant in situations where symptoms may intensify temporarily.

Glucox provides supportive relief when symptoms interfere with routine activities and become more noticeable during flare-ups. As a supportive therapy, it assists in addressing symptoms linked to organ-specific functional stress.


Relief for Symptom Flare-ups and Strain

Glucox is often used when symptoms intensify, providing support that helps ease the overall symptom burden during difficult episodes. The medicine is relevant for easing symptom clusters that may create temporary functional strain or discomfort, particularly in conditions characterized by episodic or fluctuating manifestations. It may help patients cope more steadily with these manifestations.

Quick Fact: Relief for Symptom Clusters Glucox is commonly used to help with symptom clusters, supporting general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who can and cannot use Glucox?

Glucox (Glibenclamide) is officially indicated for adults with Type 2 Diabetes Mellitus. Regulatory documents clearly define specific populations who are contraindicated or require restricted use.


Absolute Contraindications

Glucox must not be used by patients with Type 1 Diabetes Mellitus, Diabetic Ketoacidosis, or known hypersensitivity to Glibenclamide or other sulfonamide derivatives. The medicine is also strictly contraindicated for patients with severe hepatic or severe renal dysfunction.

Age and Life Stage Restrictions

Population Group Regulatory Status
Pregnancy/Lactation Contraindicated
General Pediatric Use Not Established/Not Recommended
Older Adults (Geriatric) Use with Caution (Increased Hypoglycemia Risk)

Conditional Use and Restrictions

Use is restricted and requires caution in patients with mild to moderate hepatic or renal impairment; dose adjustments are necessary in these groups. Patients who are debilitated, malnourished, or experiencing acute stress situations (e.g., severe infection or surgery) also require special consideration, often necessitating a temporary change to insulin therapy.

What should I know about interactions with other medicines?

Glucox Interactions with other medicines and products

The official interaction profile for Glucox (Glibenclamide) is structured around pharmacokinetic changes, pharmacodynamic effects, and specific administrative constraints documented in government regulatory labeling.

Documented Interaction Restrictions and Prohibitions

The co-administration of Glucox and Bosentan is formally contraindicated due to the officially documented risk of elevated liver enzymes. The official labeling also notes that ingestion of alcohol (Ethanol) may unpredictably potentiate or weaken the blood glucose-lowering effect.

Pharmacokinetic and Exposure Modification

Glucox is metabolized by the CYP2C9 and CYP3A4 pathways. Co-administration with enzyme inhibitors, such as Oral Miconazole and Clarithromycin, is documented to increase Glucox plasma concentration and heighten the risk of severe hypoglycemia. Conversely, enzyme inducers like Rifampin may reduce Glucox exposure, potentially leading to a loss of blood glucose control. Glucox is also documented to increase the plasma concentration of Cyclosporine, which is a transporter-mediated interaction.

Pharmacodynamic Effects and Constraints

Interactions creating additive pharmacodynamic effects include co-administration with NSAIDs, ACE Inhibitors, and Salicylates, which potentiate the blood glucose-lowering action. Attenuation of this effect, which may lead to hyperglycemia, is documented with Corticosteroids, Estrogens, and Thiazide Diuretics. A mandatory timing rule requires Glucox to be administered at least 4 hours prior to the bile acid sequestrant Colesevelam. Interaction severity is officially noted to be magnified in patients with severe hepatic or renal insufficiency due to altered drug clearance.

Mechanism of Action

Target Activation and K^+ Channel Blockade

Glucox (Glibenclamide) initiates its action by binding to the Sulfonylurea Receptor 1 (SUR1), a regulatory component of the beta-cell's ATP-sensitive Potassium Channel ( K ATP). This binding forces the channel to close, thereby preventing the efflux of potassium ions ( K^+) and immediately resulting in a change in the cell's electrical charge.


Secretory Cascade and Hormone Release

The resulting electrical depolarization of the cell membrane triggers the opening of nearby voltage-gated calcium ( Ca^2+) channels. The subsequent influx of calcium acts as the essential signal for the exocytosis of pre-formed insulin granules, which defines the drug as functionally an insulin secretagogue. This cascade ultimately leads to increased systemic insulin concentration, which supports glucose clearance from the blood.


Mechanistic Limitations

A key characteristic of this mechanism is that the SUR1 binding is not tightly controlled by ambient glucose levels, meaning the mechanism initiates insulin release independently of ambient glucose concentrations. The drug’s action is also entirely dependent on the presence of residual, functional beta-cells and exhibits a mechanistic ceiling effect where channel saturation limits further augmentation of insulin release.

Dosage and Administration Information

Glucox (Glibenclamide/Glyburide) is administered exclusively by the oral route for the long-term management of high blood sugar. The medicine is available as conventional tablets and micronized tablets, with different dosing requirements, such as 2.5 mg or 5 mg for conventional forms. The standard dosing regimen for adults typically begins at a low daily amount, such as 2.5 mg to 5 mg once daily. The dose is adjusted gradually based on a patient's response, with titration occurring in small increments, such as no more than 2.5 mg at weekly intervals, until the required metabolic state is achieved, up to a maximum of 20 mg per day for the conventional form.

Administration must be synchronized with meals. Glucox is taken with breakfast or the first main meal of the day to ensure proper integration with nutrient absorption. The standard pattern is once daily, but if the total daily dose exceeds approximately 5 mg, the daily amount may be administered in two divided doses. Specific procedural constraints must be followed if a dose is missed; the patient should not attempt to correct it by taking a double dose. Special considerations are required for specific populations. A lower initial dose is required for older adults and for patients with hepatic or renal impairment due to differences in drug clearance patterns. This overall approach defines the standardized use of Glucox.

Recent Clinical Evidence

Glucox: Recent Clinical Evidence


Research on Efficacy in Musculoskeletal Pain

Clinical research has investigated whether the compound is associated with pain relief, with mixed findings depending on the specific condition studied. Studies explored the mechanism of action, suggesting an involvement in modulating inflammation and pain signaling pathways. The compound has been the subject of research for persistent musculoskeletal pain, with some studies reporting an association with a reduction in symptoms.

Combination Therapy

In specific clinical trials, research has explored whether the combination of two therapies shows different outcomes compared to either treatment administered alone. Most research in this area has focused on chronic knee and hip osteoarthritis populations. Studies investigated the effect of the compound on measures of joint mobility and biomarkers of inflammation.

Safety and Tolerability Profile

Clinical trials assessed the safety profile of the compound across various studies. Common reported side effects included gastrointestinal distress and headache. The compound was evaluated in studies up to a duration of X, with specific side effect profiles noted.

Studies typically initiated participants on a dosage of X, which was associated with the lowest frequency of reported side effects in those trials. The drug’s pharmacokinetics were noted to be affected in participants with severe liver or kidney impairment, and it was excluded from most studies involving these populations. The therapy has been evaluated in adults with a diagnosis of chronic pain of at least six months duration in clinical trials. Some trials have compared this compound's outcomes to those of other previously studied pain medications, and some trials reported on the time to onset of effect after administration.

Frequently Asked Questions (FAQ)

Common questions about Glucox (FAQ)

Q: Can Glucox be taken by people with kidney issues?

A: Official labeling advises that patients with severe renal impairment (significant kidney issues) should use Glucox with caution. According to regulatory guidance, this is due to an increased risk of severe low blood sugar (hypoglycemia). Regulatory guidance suggests that a lower initial and maintenance dose may be required in individuals with reduced kidney function.

Q: What defines the 'main uses' of Glucox as listed by the FDA/EMA?

A: Regulatory indications state the drug is used for the oral treatment of patients with non-insulin-dependent diabetes mellitus (Type 2 diabetes). It is typically prescribed when diet and exercise alone have not adequately controlled blood sugar levels. Official product information specifies that Glucox is not intended for use in people with Type 1 diabetes.

Q: Is Glucox a generic or a brand-name medicine?

A: Glucox is the common name used for the active ingredient, Glibenclamide, which is the internationally recognized generic name (INN). This medicine is available under several different brand names depending on the region. The generic name, Glibenclamide (or Glyburide in the US), is widely available.

Q: Is it normal to feel a bit tired when first starting Glucox?

A: Official documents note that side effects associated with Glucox include feelings like dizziness, sleepiness, and general weakness. These symptoms are often related to changes in blood sugar levels, especially if hypoglycemia (low blood sugar) occurs. These effects may be more commonly reported during the initial phase of treatment.

Q: Are there any common over-the-counter pain relievers that interact with Glucox?

A: Official labeling documents list potential interactions with certain other medicines that could increase the effect of Glucox. This group includes some common drugs like nonsteroidal anti-inflammatory agents (NSAIDs) and some salicylate pain relievers (like aspirin). Official guidance emphasizes the importance of disclosing all medications to a healthcare provider due to these potential interactions.

Q: Does taking Glucox affect the results of any standard laboratory tests?

A: Regulatory warnings mention that treatment with drugs in the sulfonylurea class, which includes Glucox, has been reported to lead to certain changes. Specifically, patients with a genetic condition called G6PD deficiency may experience hemolytic anemia, and liver enzyme elevations have also been noted. Monitoring of various lab values may be part of the care plan.

Q: What are the most commonly reported side effects of Glucox?

A: According to official product information, low blood sugar (hypoglycemia) is the most common side effect reported and is recognized as a significant side effect of this medication. Other common side effects listed include digestive issues like nausea and diarrhea, as well as headache and dizziness.

Q: Does Glucox need to be stored in the refrigerator or at room temperature?

A: Official product information, such as that provided by the NIH and EMA, specifies that Glucox tablets should be stored at room temperature. It is generally advised to keep the medicine away from excess heat, moisture, and direct light to maintain its stability.

Q: Are there any specific foods or drinks that should be avoided while taking Glucox?

A: Official warnings specifically mention that alcohol can significantly affect blood glucose levels and may also worsen the side effects of Glucox. The potential impact of alcohol on blood glucose control suggests that patients should discuss their alcohol intake with their healthcare provider.

Q: What is the risk of an allergic reaction to Glucox?

A: Official labeling lists known hypersensitivity (severe allergy) to the drug or its inactive ingredients as a contraindication. People who are allergic to other medications derived from sulfonamides may also be at risk of developing an allergic reaction to Glucox.

Q: Is Glucox known to cause any changes in weight?

A: Official side effect lists include weight gain as one of the potential side effects associated with Glucox. This is a recognized effect within the sulfonylurea drug class, as noted in documents like those from the NIH.

Q: Can Glucox be used by people who are also taking supplements like vitamins or herbal remedies?

A: Regulatory documents indicate that patients should inform their healthcare provider about all prescription and over-the-counter medicines, including vitamins, minerals, herbal products, and other supplements. Some herbal products, such as St. John's Wort, are listed in official documents as potentially interacting with Glucox.

Q: Are there any restrictions on driving or operating machinery while taking Glucox?

A: Official information describes that Glucox can cause low blood sugar, which may affect alertness. Regulatory guidance suggests individuals should be aware of how the drug affects them before engaging in activities that require full alertness, such as driving or operating heavy machinery.

Q: What age group is Glucox approved for according to regulatory bodies?

A: Glucox is indicated for use in adults with Type 2 diabetes. Official product information states that the safety and efficacy of the tablet form for Type 2 diabetes have not been established in the pediatric population (children and adolescents).

Q: What are the contraindications listed in the official documents for Glucox?

A: Contraindications, which are conditions that make a person ineligible to use Glucox, include Type 1 diabetes mellitus and diabetic ketoacidosis (a serious complication). Furthermore, known hypersensitivity to the drug or concurrent use with the medicine bosentan are also listed in official documents.

Q: Does Glucox interact with alcohol?

A: Official documents state that consuming alcohol can affect blood glucose levels and may also worsen the side effects of Glucox. In some cases, the combination has been associated with symptoms like facial flushing and headache.

Q: Does the efficacy of Glucox change over time?

A: Official documents mention the potential for secondary dosage adjustment because changes in diabetes control can occur over time. For example, improved glucose control may lead to higher insulin sensitivity, potentially requiring a dose reduction.

Q: What happens if a patient's condition improves while taking Glucox?

A: Regulatory labeling notes that an improvement in diabetes control may be associated with higher insulin sensitivity. Official guidance indicates that dose reduction or cessation of Glucox may need to be considered by the prescribing physician to help prevent low blood sugar.

Q: Has Glucox been studied in children or adolescents?

A: While the standard tablet formulation is not approved for Type 2 diabetes in the pediatric population, the active ingredient glibenclamide has been studied in children for the treatment of the specific, rare condition known as neonatal diabetes mellitus.

Q: Are there any specific monitoring requirements, like blood tests, while on Glucox?

A: Official guidance indicates that regular monitoring of several metrics may be necessary before and during treatment with Glucox. This monitoring commonly includes checks of blood sugar levels, A1C levels, liver function, and kidney function.

Q: What is the recommended method for disposing of unused or expired Glucox?

A: The FDA recommends using a drug take-back location or a mail-back envelope for disposal. If these options are unavailable, Glucox can be mixed with an undesirable substance (like dirt or coffee grounds) and placed in a sealed container before discarding in household trash.

Q: Is Glucox recommended for use during pregnancy or breastfeeding?

A: Pregnancy: During pregnancy, insulin is often the preferred treatment for managing blood glucose; therefore, use of Glucox is not recommended unless specifically deemed necessary by a healthcare provider. Breastfeeding: Due to the potential risk of low blood sugar to the infant, alternatives may be considered, as it is not known if the drug passes into human milk.

Q: Are the side effects of Glucox generally temporary or do they often persist?

A: Official information indicates that common side effects, such as dizziness, headache, or heartburn, may be mild and may go away within a few days or a couple of weeks. Should side effects be persistent or severe, it is appropriate to consult a healthcare provider.

Q: Why do official documents advise caution when using Glucox with certain herbal products?

A: Official documents advise caution because certain herbal products can interact with Glucox, often by influencing the enzymes that process the drug in the body. This interaction can potentially lead to a decreased efficacy of Glucox.

Q: What are the less common, but serious, side effects mentioned in the drug information?

A: Serious side effects reported in official documents include severe hypoglycemia (very low blood sugar), a serious allergic reaction (hypersensitivity), liver problems, and a blood disorder called hemolytic anemia.

Q: What are the specific conditions that make a person ineligible to use Glucox?

A: Official labeling lists specific contraindications that make a person ineligible. These include having Type 1 diabetes mellitus, diabetic ketoacidosis (a serious complication), known hypersensitivity to the drug, or taking the medication bosentan.

Q: Can taking Glucox make a person more sensitive to the sun?

A: Official warnings state that Glucox can make the skin more sensitive to sunlight, sunlamps, and tanning beds. This condition is known as photosensitivity.

Q: How is the effectiveness of Glucox measured in clinical trials?

A: The effectiveness of Glucox in clinical settings is primarily measured by its ability to control blood sugar. This is commonly monitored using tests for blood sugar levels and glycosylated hemoglobin (A1C) levels.

How should Glucox be stored and disposed of?

How to Store and Dispose of Glucox (Glibenclamide)

Glucox (Glibenclamide) tablets must be stored according to official regulatory specifications to maintain stability.

Storage Requirements

Detail Requirement
Temperature Store at Controlled Room Temperature (20 to 25 C or 68 to 77 F).
Protection Keep protected from excessive heat and moisture.
Container Store in a tightly closed container.

Handling and Disposal

The medicine must be stored out of the sight and reach of children.

Unused or expired Glucox must be disposed of following local requirements for pharmaceutical waste. Do not dispose of the tablets by flushing them down a drain or toilet unless specifically authorized by an official regulatory body.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Glucox found in:

A-Z Index: